HDL Update: Age Related Changes, Mortality Risk From All Causes And Progress Towards the Optimal Range
Here is my latest video.
I created a HDL Video in November 2020 based on the meta-analysis of 3.4 millions subjects published in July 2020. In December 2020, an even larger study (n=15.8 millions subjects) was published. These data are presented and compared with the meta-analysis.
How am I doing in terms of getting my HDL into the ideal range? I also try to determine clinical significance through a correlation between higher HDL and lower Lp(a), hsCRP, etc.
The video includes references to the following studies:
A prospective cohort study of 15,8 million adults reveals the relationship between high-density cholesterol and mortality from all causes.
https://pubmed.ncbi.nlm.nih.gov/33313654/
A pooled analysis from 37 prospective cohorts studies shows that HDL-C is linked to mortality, cancer and cardiovascular disease in a J shape dose-response pattern.
https://pubmed.ncbi.nlm.nih.gov/32283957/
Use of Lipoprotein (a) in Clinical Practice: A Biomarker that is now needed. National Lipid Association scientific statement:
https://pubmed.ncbi.nlm.nih.gov/31147269/
CRP studies:
Comparison of C-reactive and cystatin C for beta2-microglobulin risk stratification in elderly populations:
https://pubmed.ncbi.nlm.nih.gov/31147269/
High-Sensitivity CR-Reactive Protein in Japanese Population and Risks for Mortality from All Causes and Cause-Specific Mortality:
https://pubmed.ncbi.nlm.nih.gov/27268644/
Source:
